ANDA 062739

LILLY

FDA Drug Application

Application #062739

Application Sponsors

ANDA 062739

LILLY

Marketing Status

• Discontinued: 001
• Discontinued: 002

Application Products

001	INJECTABLE;INJECTION	1GM/VIAL	0	TAZIDIME IN PLASTIC CONTAINER	CEFTAZIDIME
002	INJECTABLE;INJECTION	2GM/VIAL	0	TAZIDIME IN PLASTIC CONTAINER	CEFTAZIDIME

FDA Submissions

	ORIG	1	AP	1986-07-10
MANUF (CMC); Manufacturing (CMC)	SUPPL	2	AP	1987-01-23
MANUF (CMC); Manufacturing (CMC)	SUPPL	3	AP	1986-10-30
LABELING; Labeling	SUPPL	4	AP	1992-02-14
LABELING; Labeling	SUPPL	5	AP	1992-02-14
LABELING; Labeling	SUPPL	6	AP	2007-12-07
MANUF (CMC); Manufacturing (CMC)	SUPPL	7	AP	1993-04-02
MANUF (CMC); Manufacturing (CMC)	SUPPL	8	AP	1993-10-18
LABELING; Labeling	SUPPL	9	AP	1996-02-26
LABELING; Labeling	SUPPL	10	AP	1996-07-15

Submissions Property Types

SUPPL	1	Null	0
SUPPL	2	Null	0
SUPPL	3	Null	0
SUPPL	7	Null	0
SUPPL	8	Null	0

CDER Filings

cder:Array
(
    [0] => Array
        (
            [ApplNo] => 62739
            [companyName] => 
            [docInserts] => ["",""]
            [products] => []
            [labels] => 
            [originalApprovals] => []
            [supplements] => 
            [actionDate] => 0000-00-00
        )

)